Evaluation of prediabetes patients in terms of metabolic syndrome

Basit Öğe Kaydı
dc.authorscopusid57201006808
dc.authorscopusid57213385221
dc.authorscopusid26435108700
dc.authorscopusid57535532500
dc.contributor.authorGenc S.
dc.contributor.authorEvren B.
dc.contributor.authorAydin M.N.
dc.contributor.authorSahin I.
dc.date.accessioned2024-08-04T20:00:48Z
dc.date.available2024-08-04T20:00:48Z
dc.date.issued2024
dc.departmentİnönü Üniversitesien_US
dc.description.abstract– OBJECTIVE: Prediabetes accompanied by metabolic syndrome accelerates the process leading to diabetes and causes an increase in complications. The current study aimed to investigate the clinical conditions accompanying prediabetes and the effect of the association of metabolic syndrome on clinical outcomes in prediabetics. SUBJECTS AND METHODS: This cross-sectional study was conducted with 88 prediabetic individuals between November 2022 and January 2023. Prediabetes was diagnosed using the American Diabetes Association (ADA) criteria, and metabolic syndrome was diagnosed using the International Diabetes Federation criteria. Clinical history, physical examination and laboratory tests of the participants were recorded. RESULTS: Metabolic syndrome (MetS) was present in 69 of 88 prediabetic patients included in the study (78.4%). Hypertension (p=0.019), abdominal obesity (p<0.001), low-density lipoprotein (LDL) elevation (p=0.006), and dyslipidemia (p=0.020) were detected more frequently in prediabetic individuals accompanied by MetS. Median values of waist circumference (p=0.020), systolic blood pressure (p=0.021), triglyceride (p<0.001), LDL (p=0.003) and postprandial blood sugar (p=0.049) in prediabetics accompanied by MetS were statistically significant. It was higher than those without MetS. The median Vit-D level of prediabetics without MetS was higher than those with MetS (p=0.049). The median creatinine value of prediabetics without MetS was higher than that of prediabetics with MetS (p=0.049). CONCLUSIONS: Hypertension, dyslipidemia, abdominal obesity, and metabolic obesity increased in the coexistence of prediabetes and MetS. At the same time, the coexistence of prediabetes and MetS was associated with higher systolic blood pressure, postprandial blood sugar, and LDL levels. Prediabetic individuals accompanied by MetS are at greater metabolic risk. © 2024 Verduci Editore s.r.l. All rights reserved.en_US
dc.identifier.doi10.26355/eurrev_202404_35904
dc.identifier.endpage2769en_US
dc.identifier.issn1128-3602
dc.identifier.issue7en_US
dc.identifier.pmid38639515en_US
dc.identifier.scopus2-s2.0-85191106072en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage2760en_US
dc.identifier.urihttps://doi.org/10.26355/eurrev_202404_35904
dc.identifier.urihttps://hdl.handle.net/11616/91023
dc.identifier.volume28en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherVerduci Editore s.r.len_US
dc.relation.ispartofEuropean Review for Medical and Pharmacological Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAbdominal obesityen_US
dc.subjectBlood pressureen_US
dc.subjectDyslipidemiasen_US
dc.subjectMetabolic Syndromeen_US
dc.subjectPrediabetesen_US
dc.titleEvaluation of prediabetes patients in terms of metabolic syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu